J. Michel

1.2k citations

24 papers · 903 indexed · h-index 15

Impact in

Oncology top 5%
- Lung Cancer Research Studies
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Treatment and Pharmacology
Pulmonary and Respiratory Medicine top 5%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Brain Metastases and Treatment

Papers in

Oncology 16
- Lung Cancer Research Studies 12
- Cancer Treatment and Pharmacology 4
Pulmonary and Respiratory Medicine 9
- Lung Cancer Treatments and Mutations 6
- Brain Metastases and Treatment 2

Co-authors: Jean‐Paul Sculier P Libert O Van Cutsem G. Bureau P. Mommen R Sergysels G Dabouis Marianne Paesmans
Journals: Journal of Clinical Oncology (4 papers)Lung Cancer (2 papers)Annals of Oncology (2 papers)Cancer (1 paper)British Journal of Cancer (1 paper)
Partner nations: Belgium France

In The Last Decade

J. Michel

21 papers receiving 850 citations

Peers

Countries citing papers authored by J. Michel

Since Specialization

Citations

This map shows the geographic impact of J. Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Michel more than expected).

Fields of papers citing papers by J. Michel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Michel. The network helps show where J. Michel may publish in the future.

Co-authors

The 25 scholars most cited alongside J. Michel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J. Michel Line = papers co-authored together J. Michel links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Induction Chemotherapy with Cisplatin, Etoposide and Vindesine before Radiation Therapy for Nonsmall-Cell Lung Cancer Antibiotics and chemotherapy/Antibiotica et chemotherapia ·P. Van Houtte, Jean Klášterský, A. Renaud, J. Michel, G. Vandermoten, Hien Xuan Nguyen, J.P. Sculier, Jacques Devriendt, P. Mommen	2015	0
2	Autochthonous white rot fungi from the tropical forest: Potential of Cuban strains for dyes and textile industrial effluents decolourisation AFRICAN JOURNAL OF BIOTECHNOLOGY ·Isabel María, F Vanhulle Sophie, Mertens Valeacute rie, G Leitao Gilda, Herrera Figueroa Sara, Decock Cony, Corbisier Anne Marie, J. Michel	2008	17
3	A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics British Journal of Cancer ·(unknown), Sculier Jp, M Paesmans, J. Lecomte, O Van Cutsem, J.J. Lafitte, T. Berghmans, George Koumakis, M Florin, J Thiriaux, J. Michel, V. Giner, M.C. Berchier, P. Mommen, Vincent Ninane, Jean Klášterský	2001	41
4	Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party European Journal of Cancer ·Marianne Paesmans, Jean‐Paul Sculier, P Libert, G. Bureau, G Dabouis, J Thiriaux, J. Michel, O Van Cutsem, R Sergysels, P. Mommen, Jean Klášterský	1997	71
5	Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC) Lung Cancer ·Marcela Maria Fontes Borges, Jean‐Paul Sculier, Marianne Paesmans, Michel Richez, G. Bureau, G Dabouis, J. Lecomte, J. Michel, O Van Cutsem, J Schmerber, V. Giner, M.C. Berchier, R Sergysels, P. Mommen, Jean Klášterský	1996	24
6	Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology ·Jean‐Paul Sculier, M Paesmans, G. Bureau, V. Giner, J. Lecomte, J. Michel, M.C. Berchier, O Van Cutsem, U Küstner, Frode Krøll, R Sergysels, P. Mommen, Jean Klášterský	1996	54
7	Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. Journal of Clinical Oncology ·Marianne Paesmans, Jean‐Paul Sculier, P Libert, G. Bureau, G Dabouis, J Thiriaux, J. Michel, O Van Cutsem, R Sergysels, P. Mommen	1995	341
8	Dose-finding study of tropisetron in cisplatin-induced nausea and vomiting Annals of Oncology ·Simon J. P. Van Belle, Lambert Stamatakis, Harry Bleiberg, V. Cocquyt, J. Michel, K.M. de Bruijn	1994	13
9	Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party. Journal of Clinical Oncology ·Jean‐Paul Sculier, Marianne Paesmans, G. Bureau, G Dabouis, P Libert, G. Vandermoten, O Van Cutsem, M.C. Berchier, F. Ries, J. Michel	1993	61
10	Experience of the Belgian Society of Medical Oncology with single-administration 5 g/m2 ifosfamide with mesna as second- or third-line therapy in advanced breast cancer Cancer Chemotherapy and Pharmacology ·R. Paridaens, C. Focan, J. Michel, Martine Piccart, E. Salamon, M. Beauduin, Marie-Thérèse Closon, Elias Tueni, A. Vindevoghel, F. Majois, M. T'Hooft-Andry	1990	8
11	A randomized study comparing etoposide and vindesine with or without cisplatin as induction therapy for small cell lung cancer Annals of Oncology ·Jean‐Paul Sculier, Jean Klášterský, P Libert, P Ravez, J Thiriaux, J. Lecomte, G. Bureau, G. Vandermoten, G Dabouis, J. Michel, J Schmerber, R Sergysels, D. Becquart, P. Mommen, M. Paesmans	1990	18
12	Oral versus intramuscular high-dose medroxyprogesterone acetate (HD-MPA) in advanced breast cancer. A randomized study of the Belgian Society of Medical Oncology. PubMed ·Robert Paridaens, D. Becquart, J. Michel, Bruno Vanderlinden, J Longueville, F. Majois, M. Beauduin, C. Focan, J. Wildiers, J. Bernheim	1987	8
13	A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma. Journal of Clinical Oncology ·Jean Klášterský, Jean‐Paul Sculier, P Ravez, P Libert, J. Michel, G. Vandermoten, P Rocmans, Y. Bonduelle, M Mairesse, T. Michiels	1986	117
14	Combination chemotherapy with cisplatin, etoposide, and vindesine in non-small cell lung carcinoma: a clinical trial of the EORTC lung cancer working party. PubMed ·Jean Klášterský, Jean‐Paul Sculier, Claude Nicaise, Danièle Weerts, M Mairesse, P Libert, P Rocmans, J. Michel, W Ferremans	1983	25
15	Phase II trial with chlorozotocin in advanced colorectal cancer European Journal of Cancer and Clinical Oncology ·Harry Bleiberg, Marcel Rozencweig, J. Michel, M. Clavel, E Longeval, Walter Feremans, H. Bondue, J Lardinois, N. Crespeigne, Y. Kenis	1981	3
16	Adjuvant immunotherapy by levamisole in resectable lung cancer: A control study European Journal of Cancer (1965) ·P. Van Houtte, H. Bondue, P Rocmans, J. Michel, Joseph Wybran, Otilia Dalesio, D Balikdjian, P Vanderhoeft, Y. Kenis	1980	14
17	Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) ·G. De Wasch, J. Bernheim, J. Michel, Ferdinand Lejeune, Yvon Kenis	1976	15
18	Combination chemotherapy with 1-(2-chloroethyl-3-cyclohexyl-1-nitrosourea) (CCNU), vincristine and methotrexate in primary and metastatic brain tumors—A preliminary report European Journal of Cancer (1965) ·Jerzy Hildebrand, J Brihaye, L. Wagenknecht, J. Michel, Y. Kenis	1973	21
19	Hodgkins' disease with massive hepatic involvement and uninvolved spleen European Journal of Cancer (1965) ·J. Michel, D Ardichvili, M Somerhausen, Y. Kenis, Jean-Claude Heuson	1973	0
20	THROMBOCYTOSIS, METHOTREXATE, AND CITROVORUM FACTOR The Lancet ·Y. Kenis, J. Michel, H. J. Tagnon	1970	2

About J. Michel

J. Michel is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Hepatology, Epidemiology and Pathology and Forensic Medicine, having authored 24 papers that have together received 903 indexed citations. Recurring topics across this work include Lung Cancer Research Studies (12 papers), Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Treatment and Pharmacology (4 papers), Cancer therapeutics and mechanisms (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Brain Metastases and Treatment (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (662 citations), Pulmonary and Respiratory Medicine (504 citations), Epidemiology (201 citations), Otorhinolaryngology (21 citations) and Cancer Research (66 citations). J. Michel has collaborated with scholars based in Belgium and France. Frequent co-authors include Jean‐Paul Sculier, P Libert, O Van Cutsem, G. Bureau, P. Mommen, R Sergysels, G Dabouis, Marianne Paesmans, J Thiriaux and Jean Klášterský. Their work appears in journals such as Journal of Clinical Oncology, Lung Cancer, Annals of Oncology, Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact